Illumina this week introduced a new family of "cost-efficient" genotyping arrays geared toward biobanks, genome centers, and core labs.

Several of the company's customers welcomed the chips' debut, saying that the new arrays will support ongoing efforts to discover and characterize common and low-frequency variants in large sample cohorts.

And Affymetrix, Illumina's main competitor in the genotyping array market, pledged this week to soon launch arrays for large screening studies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.